May 16, 2023, 17:31 by Molly McGrath

On May 16th, the American Society of Addiction Medicine, along with nearly 100 stakeholder organizations, sent a letter to Speaker McCarthy, Majority Leader Schumer, Minority Leader Jeffries, Minority Leader McConnell, and the Chairs and Ranking Members of the House of Representatives Energy & Commerce and Judiciary Committees, and of the Senate Health, Education, Labor, and Pensions Committee, to express their strong support of the Modernizing Opioid Treatment Access Act of 2023 ("the M-OTAA of 2023," H.R. 1359, S. 644).

May 11, 2023, 14:04 by Molly McGrath

On May 10th, the Alabama Society of Addiction Medicine (ALSAM) sent a letter in support of HB433/SB239 to members of the House Committee on Health. In light of the removal of the federal “X-waiver,” this legislation would repeal a previous state law requiring the Alabama Board of Medical Examiners to adopt rules governing the prescribing and use of buprenorphine to treat opioid use disorder (OUD) in nonresidential settings.

May 11, 2023, 10:07 by Molly McGrath

On May 10th, national organizations, including the American Society of Addiction Medicine, the American College of Emergency Physicians, the American Psychological Association, the American Psychiatric Association, and Faces and Voices of Recovery, held a briefing for the 118th Congress, and strongly encouraged a national response to the deadly substance use and addiction crisis that has left no American community untouched.

May 10, 2023, 10:04 by ASAM Weekly Editors

Management of Stimulant Use Disorders

May 8, 2023, 17:59 by Molly McGrath

May 8, 2023, 17:31 by Molly McGrath

The Centers for Medicare and Medicaid Services (CMS) issued two proposed rules on April 27, 2023 to strengthen beneficiary access and quality of care in Medicaid and the Children's Health Insurance Program (CHIP), the largest health coverage programs.

May 3, 2023, 09:08 by ASAM Weekly Editors

The Hedonic Amplification of Feeding

Apr 26, 2023, 12:18 by ASAM Weekly Editors

Opioid Prescribing and Suicide Risk in the US

Apr 19, 2023, 11:03 by ASAM Weekly Editors

Association Between Daily Alcohol Intake and Risk of All-Cause Mortality

Apr 18, 2023, 06:52 by Molly McGrath

On April 17th, ASAM joined 125 other organization in endorsing the Reentry Act, which would allow incarcerated individuals to receive medical services supported by Medicaid thirty days prior to the individual's release and is currently prohibited by the Medicaid Inmate Exclusion Policy (MIEP).

Apr 17, 2023, 11:01 by Maciek Gregorski

The American Society of Addiction Medicine (ASAM) proudly announces its new Board of Directors for the 2023-2025 term

Apr 14, 2023, 12:02 by Molly McGrath

Apr 12, 2023, 09:27 by ASAM Weekly Editors

Genetic Liability for Alcohol Consumption, Alcohol Problems and Suicide Attempts

Apr 10, 2023, 15:40 by Molly McGrath

On April 10th, the Northern New England Society of Addiction Medicine (NNESAM) sent a letter to members of the Maine Legislature’s Joint Committee on Health and Human Services in support of LD 1159.

Apr 5, 2023, 10:59 by ASAM Weekly Editors

Genetic Loci Underlying Multiple Substance Use Disorders

Mar 29, 2023, 17:25 by Molly McGrath

On March 29th, ASAM provided comments to the Office of National Drug Control Policy (ONDCP). recommending it include actions in the 2024 biennial national drug control strategy that call for the decoupling criminal penalties and personal drug use possession, implemented as part of a carefully designed set of public health and legal reforms that include strategic, social investments to strengthen American communities and improve lives.

Mar 29, 2023, 14:46 by Molly McGrath

On March 27th, the Arkansas Society of Addiction Medicine (ARSAM) sent a letter to members of the Senate Committee on Insurance and Commerce expressing support for removing prior authorization on injectable medications for addiction treatment (MAT) and proposing improvements to strengthen the provisions of HB 1558.

Mar 29, 2023, 09:20 by ASAM Weekly Editors

Human brain effects of DMT assessed via EEG-fMRI

Mar 27, 2023, 18:32 by Molly McGrath

On March 27th, ASAM provided comments to the Drug Enforcement Administration's (DEA) notice of proposed rulemaking (NPRM) regarding the expansion of induction of buprenorphine via telemedicine encounter.

Mar 24, 2023, 11:52 by Molly McGrath

On March 24th, the Kentucky Society of Addiction Medicine (KYSAM) sent a letter to members of Senate Committee of Health Services supporting HB 353.